1. Eckstein R, Mempel W, Bolte HD. Reduced suppressor cell activity in congestive cardiomyopathy and myocarditis. Circulation 1992;65:1224?1229.
2. Koga Y, Miyazaki Y, Toshima H, et al. Lymphocyte subsets in patients with acute myopericarditis, arrhythmias and dilated cardiomyopathy. Jpn Circ J 1989;53:78?86.
3. Shiokawa Y, Horiuchi Y, Mizushima Y, et al. A multicenter double-blind controlled study of lobenzarit, a novel immunomodulator, in rheumatoid arthritis. J Rheumatol 1984;11: 615?623.
4. Nakano T, Yamashita Y, Ohsugi Y, et al. The effect of CCA (lobenzarit disodium) on suppressor T cell function and the production of autoantibodies in New Zealand Black and New Zealand White F1 mice. Immunopharmacology 1985;5: 293?302.
5. Itoh K, Kurane I, Saito F, et al. Regulatory effect of CCA on immune responses. Clin Immunol 1983;15:242?252 (in Japanese).